This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Macrophages are essential immune cells in protecting human body from external threats such as bacterial and virus threats, while their functions switch to associate tumor development under tumor microenvironment as tumor associated macrophages (TAMs). TAMs are involved in micrometastasis niches and immune escape [1]. The population of TAMs is negatively correlated with clinical prognosis in many kinds of malignant tumors. So TAMs are considered as a new therapeutic target in the field of tumor immune therapy [2].
Macrophage polarization is two extremes of situations after mononuclear cell activation, and various microenvironment signals induce its polarization. According to different functional characteristics and its induced consequence, macrophages are usually divided into M1 and M2 [3]. Classically activated macrophages (M1) are activated by T helper (Th)-1 cytokines such as interferon gamma (IFN-γ) and bacterial wall components lipopolysaccharide (LPS). These macrophages have antitumor effect due to the cell toxicity of nitric oxide induced by inducible nitric oxide synthase (iNOS). Alternatively activated macrophages (M2) are activated with T helper (Th)-2 cytokines such as IL-4 and/or IL-13[4], which have opposite function to that of M1.
Arginase-1 (Arg-1) presents in both murine and human with M2 induction while being very low in M1 phenotype; that indicates that it is an optimal specific marker of M2. Inhibitors of Arg-1 maybe have effect on regulation immune microenvironment targeting TAMs. The expression of Arg-1 requires tight control at transcriptional level. There are several pivotal transcription factors that regulate the expression of Arg-1 such as Signal Transducers and Activators of Transcription 6 (STAT6). The expression of Arg-1 strictly depends on STAT6 in the presence of IL-4 and/or IL-13 during M2 activation [5]. Inhibition of STAT6 in TAMs attenuates tumor growth and metastasis [6].
Numerous recent studies reveal that some microRNAs (miRNAs) are involved in macrophage polarization by regulating transcription factors [7]. Among these miRNAs, miR-155 targeted IL-13Rα1 via STAT6 signal pathway to suppress M2 phenotype of macrophages [8].
According to TCM, constant motion and transformation of Qi maintain body internal balance. And the occurrence of tumor is caused by the deficiency of Qi. One of the key principles to cancer intervention guided by TCM is strengthening Qi. Qi can improve the immune system against pathogenic factors. Qi-tonifying herbs or their formulas are usually used to prevent cancer recurrence and metastasis of postoperative cancer patients in China [9].
So, we selected five Qi-tonifying herbs with high frequency in clinical practice against cancers and screened their effects on M2 macrophages.
2. Materials and Methods
2.1. Drugs and Reagents
Glycyrrhiza Radix et Rhizoma (Gancao, RC), Ginseng Radix et Rhizoma (Renshen, RS), Cordyceps (Dongchongxiacao, DCXC), Acanthopanacis senticosi Radix et Rhizoma Seu caulis (Ciwujia, CWJ), and Astragali Radix (Huangqi, HQ) were purchased from Yanghetang Pharmaceutical Company (Shanghai, China). Botanical identification of these herbs was performed by Shanghai Institute for Food and Drug Control (SIFDC). Ingredients (Table 1) were purchased from Shanghai Tauto Biotechnology Company with purity more than 98% by HPLC. Mouse IL-4 and IL-13 were purchased from Peprotech (Rockville, MD, USA). Fetal bovine serum (FBS) was purchased from Hyclone (Waltham, MA, USA). Thiazoyl 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and dimethylsulfoxide (DMSO) were purchased from Sigma (St. Louis, MO, USA). Trizol, High-Capacity cDNA Reverse Transcription Kit, Real Master Mix SYBY Green, Prestained protein Marker, and BCA protein concentration assay kit were purchased from Invitrogen (Carlsbad, CA, USA). TaqMan MicroRNA primers, transcription kit, and universal PCR master mix were obtained from Applied Biosystems (Foster City, CA, USA). PVDF membranes and ECL kit were purchased from Millipore (Bedford, MA, USA). Arg-1, iNOS antibody, and secondary antibody were purchased from Abcam (Cambridge, UK). Antibody phosphor-STAT6 and STAT6 polyclonal antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). RIPA Lysate was purchased from Beyotime Biotechnology Company (Haimen, China). Primers were synthesized by Shanghai Bioengineering Company. Other reagents were analytical grade.
Table 1
Ingredients from five herbs.
Pharmacologic name/Chinese name | Produced from | Components |
---|---|---|
Glycyrrhiza Radix et Rhizoma (Gancao, GC) | root | Glabridin, Isoliquiritin apioside, Liquiritin apioside, Glycyrrhizic acid ammonium salt, Isoliquiritin, Lysionotin |
Ginseng Radix et Rhizoma (Renshen, RS) | root | 20(S)-Ginsenoside Rg3, Ginsenoside Rg1, Ginsenoside Rf, Lysionotin, Notoginsenoside |
Cordyceps (Dongchongxiacao, DCXC) | macrofungi | Cordycepin |
Acanthopanacis senticosi Radix et Rhizoma Seu caulis (Ciwujia, CWJ) | root | Eleutheroside B, Hederasaponin B, Eleutheroside E |
Astragali Radix (Huangqi, HQ) | root | Astragaloside IV, Calycosin-7-glucoside, Calycosin |
a. Based on Chinese Pharmacopoeia (Version 2015).
2.2. Preparation of Extracts from Five Chinese Herbs
To prepare ethanol extracts, 100 g of each dried herbs was sliced and extracted with 1 L of 70% ethanol at 80°C for three times. Obtained ethanol extracts were evaporated under reduced pressure at temperature 60°C and stored at -80°C. Extracts were dissolved with DMSO before use. TFRG was obtained as described previously [10], and no endotoxin existed in it by endotoxin test.
2.3. Cell Culture
Mouse macrophage cell line RAW264.7 and mouse breast cancer cell line 4T1 were obtained from ATCC. RAW264.7 cell and breast cancer 4T1 cell were cultured in RPMI-1640 medium which contained 10% FBS, placed in saturated humidity, 5% CO2 incubator, and incubated at 37°C constant temperature. Take 10 to 15 generations of cells for these experiments.
2.4. Preparation of Conditioned Medium
RAW264.7 cells were seeded in 30mm dish and cultured overnight. Then cells were treated with/no different concentrations (25, 50μg/mL) of TFRG and IL-4 (20μg/mL)/IL-13 (20μg/mL) induction for 24 h in serum free medium. The culture supernatants (conditioned medium, CM) were collected and centrifuged to remove cellular components and stored in 4°C before use.
2.5. Cell Viability Assay
Cell viability was measured using MTT assay [10].
2.6. Trans-Well Migration Assay
Cell migration assay was performed using the Trans-well system (24-wells, 8-μm pore size, Corning Costar, Lowell, MA, USA). Briefly, 4T1 cells were harvested and suspended in serum-free medium; then 5 × 104 cells were added to the upper wells. 600μL conditioned medium from each group was added to the lower chamber. After treatment for 24 h, the cells attached to the lower surface were fixed with methanol and stained with 0.1% crystal violet. The number of cells that migrated was counted in five randomized fields using an Olympus light microscope.
2.7. qRT-PCR
Total RNA was extracted from cells using TRIzol regents according to the manufacturer's protocol. The sequences of these primers are as shown in Table 2. The level of GAPDH mRNA was used as an internal standard and Applied Biosystems 7500HT Fast Real-Time PCR System was used to perform the reactions. PCR reaction conditions were the following: 95°C for 10 minutes, 50°C for 2 minutes, 95°C for 15s, 60°C for 60s, and 40 cycles.
Table 2
The primer of mRNA sequence.
Gene name | Primer sequences |
---|---|
Arg-1 | sense 5′-CAGAAGAATGGAAGAGTCAG-3′ |
antisense 5′-CAGATATGCAGGGAGTCACC-3′ | |
FIZZ1 | sense 5′-CCAACTGTCCTAAGAATGAAGAG-3′ |
antisense 5′-AAGCAGGGTAAATGGGCAATA-3′ | |
YM1 | sense 5′-GAGTACACAGGCAGGGGTCAATAT-3′ |
antisense 5′-GCCAGCAGAAGCTCTCCAGAAG-3′ | |
CD206 | sense 5′-GCTGAATCCCAGAAATTCCGC-3′ |
antisense 5′-ATCACAGGCATACAGGGTGAC-3′ | |
GAPDH | sense 5′-AG-GTCGGTGTGAACGGATTTG-3′ |
antisense 5′-TGTAGACCATGTAGTTGAGGTCA-3′ |
2.8. TaqMan® MicroRNA Real-Time RT-PCR Assays
Mmu-miR-155 and the housekeeping gene U6 were carried out according to the manufacturer’s protocol [11]. These samples were measured in triplicate cases. U6 endogenous control was used for normalization, and expression levels were presented as
2.9. Western Blot Analysis
Cell extracts were collected using RIPA buffer and separated on 4−12% SDS-PAGE gels followed by the transfer to PVDF membrane. The membranes were blocked with 5% skim milk and incubated with the appropriate primary antibodies. Antibodies used include Arg-1, iNOS, phosphor-STAT6, STAT6, and GAPDH.
2.10. Statistical Analysis
Data were reported as the mean ± standard deviation for each individual experiment. Statistical analysis was performed using Student’s t-test. P < 0.05 was considered as significant.
3. Results
3.1. Effects of Herb Extracts and Ingredients on Arg-1 mRNA Expression and Cell Growth
These extracts and ingredients were evaluated for their effects on Arg-1 mRNA expression in IL-4/IL-13-induced murine RAW264.7 macrophages and cell growth on unstimulated macrophages with the aid of qRT-PCR and MTT.
A wide range of inhibitions in Arg-1 mRNA expression was observed with these candidates with no cell cytotoxicity (Table 3). TFRG and ethanol extract of RS showed the strong inhibition of Arg-1 mRNA expression (above 90% at 100μg/mL). The inhibition of total saponins of RS, ethanol extract of DCXC, ethanol extract of CWJ, and ethanol extract of HQ reached above 50% at 100μg/mL. The inhibition of ingredients including glabridin, isoliquiritin apioside, lysionotin, cordycepin, astragaloside IV, and calycosin reached above 50% at 50μM.
Table 3
Effect of herb extracts and ingredients on Arg-1 mRNA expression and cell viability.
Candidates | Dose | Viability | Inhibition |
---|---|---|---|
Ethanol extract of GC | 100 | 105.81±4.97 | 48.21 |
TFRG | 100 | 107.54±4.98 | 92.34 |
Glabridin | 50 | 105.02±2.00 | 84.38 |
Isoliquiritin apioside | 50 | 104.05±1.74 | 53.75 |
Liquiritin apioside | 50 | 106.79±6.20 | 41.59 |
Glycyrrhizic acid ammonium salt | 50 | 94.07±4.36 | - |
Isoliquiritin | 50 | 97.89±5.25 | - |
Liquiritin | 50 | 113.24±7.94 | - |
Ethanol extract of RS | 100 | 92.96±5.52 | 90.81 |
Total saponins of RS | 100 | 108.02±7.72 | 84.30 |
20(S)-Ginsenoside Rg3 | 50 | 95.94±4.30 | - |
Ginsenoside Rg1 | 50 | 97.82±2.08 | - |
Ginsenoside Rf | 50 | 109.62±5.32 | 15.06 |
Lysionotin | 50 | 95.42±2.57 | 50.98 |
Notoginsenoside | 50 | 94.08±5.36 | - |
Ethanol extract of DCXC | 100 | 106.66±2.38 | 87.09 |
Cordycepin | 50 | 95.83±1.64 | 84.40 |
Ethanol extract of HQ | 100 | 98.86±3.29 | 65.54 |
Astragaloside IV | 50 | 106.41±1.86 | 55.14 |
Calycosin-7-glucoside | 50 | 98.55±0.97 | 32.15 |
Calycosin | 50 | 110.52±6.19 | 77.51 |
Ethanol extract of CWJ | 100 | 95.37±8.50 | 80.65 |
Eleutheroside B | 50 | 98.97±8.25 | 30.08 |
Hederasaponin B | 50 | 98.33±7.20 | 41.51 |
Eleutheroside E | 50 | 99.08±1.01 | 20.52 |
3.2. TFRG Abolished Migration of 4T1 Induced by M2CM
Since TFRG showed the strongest inhibition of Arg-1 mRNA among these extracts without cytotoxicity, we wondered that whether TFRG can influence the function of M2 macrophage. Accumulated evidence suggests that M2 macrophages assist cancer cell to metastasis and worsen TME [12]. The conditioned medium from M2 macrophages after IL-4/IL-13 induction (M2CM) significantly improved the migration ability of breast cancer 4T1 cells in vitro. The conditioned medium from TFRG pretreatment M2 macrophages reduced the increased migration ability of 4T1 cells in a dose-dependent manner (Figure 1).
[figures omitted; refer to PDF]
3.3. TFRG Suppressed Arg-1 Expression at mRNA and Protein Level
Arg-1, a marker for the M2 subset macrophages, hydrolyzes L-arginine into urea and ornithine and inhibits nitric oxide-mediated pathways by competing with iNOS for the same substrate L-arginine [13]. In resting macrophages, low expression of Arg-1 was detected, and the expression of Arg-1 was significantly increased after IL-4/IL-13 induction towards M2 phenotype. Thus, we investigated the possibility that TFRG blocked Arg-1 expression. To test this possibility, we determined the effect of TFRG on Arg-1 expression in induced RAW264.7 cells. Results from qRT-PCR and western blotting revealed that TFRG downregulated Arg-1 expression in a dose-dependent manner at levels of gene and protein (Figure 2).
[figures omitted; refer to PDF]
3.4. TFRG Downregulated M2 Related Markers and Upregulated M1 Marker iNOS
Since TFRG is sufficient to reduce the expression of Arg-1 in M2 macrophages, we wondered whether the expression of other M2 markers can be also reduced by TFRG. We found that TFRG downregulated the M2 markers FIZZ1, YM1, and CD206 in IL-4/13 derived M2 macrophages (Figures 3(a)–3(c)). In addition, the M1 marker iNOS was impaired in macrophages towards M2, and TFRG restored the production of iNOS under the induction of M2 (Figure 3(d)).
[figures omitted; refer to PDF]
3.5. TFRG Blocked IL-4/IL-13-Induced STAT6 Activation
STAT6 signaling pathway is associated with the regulation of M2 polarization in macrophages induced by cytokines IL-4 and IL-13 [14]. To explore potential relationship between TFRG and STAT6 signaling pathway, we determined the effect of TFRG on the phosphorylation status of STAT6 in IL-4/IL-13-induced RAW264.7 cells. Western blotting showed that the level of phosphorylated STAT6 was much higher in induced M2 cells in comparison with unstimulated cells. Treatment of TFRG dependently decreased the level of phosphorylated STAT6 (Figure 4(a)). The result indicated that TFRG might exert its inhibition of M2 macrophages by the interference with STAT6 signaling pathway.
[figures omitted; refer to PDF]
3.6. TFRG Induced miR-155 Expression in M2 Macrophages
Recent evidence has demonstrated that miR-155 is involved in M2 polarization [15]. To determine the effect of TFRG on miR-155 under the induction of IL-4/IL-13 in RAW264.7 cells, we pretreated cells with TFRG prior to induction. qRT-PCR showed that IL-4/IL-13 led to the decrease of the expression of miR-155 comparing with unstimulated cells. TFRG dramatically increased the level of miR-155 in RAW264.7 cells challenged by IL-4/13. It suggested that TFRG may prevent M2 polarization via miR-155 (Figure 4(b)).
4. Discussion
Despite the effectiveness of conventional therapies that include surgery, radiotherapy, and chemotherapy that focus on tumor cells, the survival time of cancer patients is still unsatisfying after clinical treatment. TME and its components play a critical role in recurrence and metastasis [16]. Considering the essential role of macrophages in the progression of tumor, an increasing attention has been exerted on regulating their polarization to help better clinical diagnosis, prognosis, and therapeutic applications [17]. Natural products from TCM are always evaluated on proliferation of tumor cells, and further efforts should be made to evaluate their regulation on immune cells such as TAMs.
TCM theory was developed during thousand years of clinical experience fighting against diseases, and the key principle of TCM cancer treatment is to strengthen Qi. Herbs with Qi-tonifying characteristic such as RS, DCXC, and HQ have been used with high frequency to ameliorate symptoms of insufficiency and reduction of Qi in cancer patients during tumor development or chemotherapeutic drugs administration [18]. However, Qi-tonifying herbs usually have no or less cell cytotoxicity to cancer cells. Thus, we hypothesize that Qi-tonifying herbs may have effect on M2 phenotype regulation to improve TME.
Arg-1 is well established as a major marker of M2 macrophages. Tumors of Arg-1-deficient mice were about half the size comparing with those of wild-type mice, suggesting that Arg-1 in TAMs has an essential role in tumor growth by producing polyamines to promote cell proliferation [19].
In this present study, taking advantage of the M2 phenotype cell model induced by IL-4/IL-13 on macrophage RAW264.7, we evaluated extracts and ingredients from five Qi-tonifying herbs for their inhibitory effects on IL-4/IL-13-induced Arg-1 expression. We revealed that 6 extracts and 6 compounds markedly inhibited polarization of macrophages toward M2 phenotype via inhibiting Arg-1 mRNA.
Among them, TFRG showed the strongest inhibitory effect on Arg-1 mRNA. The mechanisms of TFRG in regulating M2 polarization events need to be explored. Previous studies showed that TFRG could inhibit the growth of tumor on nude mice bearing breast cancer [10]. Nevertheless, it remains unknown whether TFRG could inhibit breast cancer by targeting TAMs. So, we evaluated the regulatory effect of TFRG on TAMs in vitro.
Macrophages in tumor tissues were mostly polarized to M2 phenotype. The M2-polarized macrophages derived by IL-4, IL-13, IL-10, and glucocorticoids express high levels of Arg-1, CD206 (MRC1), TGFβ, MMPs, FIZZ1, and YM1, which could promote the metastasis and angiogenesis of tumors [20]. Figure 1 showed that RAW264.7-M2CM attracted 4T1 to elevate its migration, a decreased chemotactic effect of TFRG treated M2-CM to 4T1 breast cells. Figure 2 demonstrated that TFRG could regulate the polarization of macrophages by decreasing the expression of M2-phenotype markers Arg-1 at levels of gene and protein.
Studies have shown that the expression of Arg-1 and iNOS is competitive regulation by Th1 and Th2 cytokines. Arg-1 is induced in response to Th2 cytokines such as IL-4 or IL-13, while iNOS is associated with Th1 cytokines including IFN-γ with/not LPS. Arg-1 competes with iNOS for they both can utilize L-arginine as substrate to produce L-ornithine and urea or L-citrulline and NO, respectively [21]. Increased Arg-1 activity reduced availability of L-arginine as the substrate for iNOS in M2 macrophages to limit the antitumor production NO of iNOS. TFRG not only decreased the Arg-1 expression, but also increased the expression of iNOS at the same time (Figures 2 and 3).
The STAT6 signaling pathway is well recognized for its role in the expression of Arg-1 on M2 macrophages induced by IL-4 [22]. By examining the effect of TFRG on the phosphorylation status of STAT6, we found that the level of phosphorylated STAT6 was reduced notably by TFRG (Figure 4(a)). Current studies have revealed a critical role of miR-155 in M2 polarization [23]. Figure 4(b) showed that the level of miR-155 was upregulated by TFRG. We reason that TFRG at least partially acts through increasing the amount of miR-155 in alternatively activated macrophages.
In conclusion, these active extracts and compounds from Qi-tonifying herbs based on M2 macrophage cell model screening may be useful in anticancer therapy by targeting the immunosuppressive activity of TAMs. TFRG is a potential candidate agent for anticancer therapy due to its antitumor effect and immunomodulation, which could inhibit the promoted migration of 4T1 by M2-CM and suppress the polarization of M2, partly via regulating STAT6 signaling pathway and miR-155 expression.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Authors’ Contributions
Yi-Xin Jiang, Yan Chen, and Yue Yang contributed equally to this work.
Acknowledgments
This work was supported by Funds of the National Natural Science Foundation of China (81773946, 81573673, and 81001666), Innovation Project for Undergraduates of Shanghai University of Traditional Chinese Medicine (2017SHUTCM118), the Young Scientists Fund of Shanghai Municipal Commission of Health and Family Planning (20144Y0143), Innovation Program of Shanghai Municipal Education Commission (13YZ048), and the Foundation of Shanghai Education Commission for Outstanding Young Teachers in University (SZY07029).
Glossary
Abbreviations
TAMs:Tumor-associated macrophages
TME:Tumor microenvironment
TCM:Traditional Chinese Medicine
qPCR:Quantitative real-time polymerase chain reaction
Arg-1:Arginase-1
FIZZ1:Found in inflammatory zone 1
YM1:Chitinase-3-like protein 3
CD206:Mannose receptor C type 1
iNOS:Inducible nitric oxide synthase
miR-155:miRNA-155
STAT6:Signal transducer and activator of transcription 6
TFRG:Total Flavonoids from Radix Glycyrrhiza.
[1] P. J. Murray, J. E. Allen, S. K. Biswas, "Macrophage activation and polarization: nomenclature and experimental guidelines," Immunity, vol. 41 no. 1, pp. 14-20, DOI: 10.1016/j.immuni.2014.06.008, 2014.
[2] P. Italiani, D. Boraschi, "From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation," Frontiers in Immunology, vol. 5,DOI: 10.3389/fimmu.2014.00514, 2014.
[3] A. Sica, A. Mantovani, "Macrophage plasticity and polarization: in vivo veritas," The Journal of Clinical Investigation, vol. 122 no. 3, pp. 787-795, DOI: 10.1172/JCI59643, 2012.
[4] T. A. Wynn, A. Chawla, J. W. Pollard, "Origins and Hallmarks of Macrophages: Development, Homeostasis, and Disease," Nature, vol. 496 no. 7446, pp. 445-455, 2013.
[5] M. Sanson, E. Distel, E. A. Fisher, "HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process," PLoS ONE, vol. 8 no. 8,DOI: 10.1371/journal.pone.0074676, 2013.
[6] K. Binnemars-Postma, R. Bansal, G. Storm, J. Prakash, "Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer," The FASEB Journal, vol. 32 no. 2, pp. 969-978, DOI: 10.1096/fj.201700629R, 2018.
[7] H. Li, T. Jiang, M. Q. Li, "Transcriptional Regulation of Macrophages Polarization by MicroRNAs," Frontiers in Immunology, vol. 9,DOI: 10.3389/fimmu.2018.01175, 2018.
[8] R. T. Martinez-Nunez, F. Louafi, T. Sanchez-Elsner, "The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor α 1 (IL13R α 1)," The Journal of Biological Chemistry, vol. 286 no. 3, pp. 1786-1794, DOI: 10.1074/jbc.m110.169367, 2011.
[9] K. Seki, M. Chisaka, M. Eriguchi, H. Yanagie, T. Hisa, I. Osada, T. Sairenji, K. Otsuka, F. Halberg, "An attempt to integrate Western and Chinese medicine: Rationale for applying Chinese medicine as chronotherapy against cancer," Biomedicine & Pharmacotherapy, vol. 59, pp. S132-S140, DOI: 10.1016/S0753-3322(05)80021-6, 2005.
[10] Y.-X. Jiang, Y.-Y. Dai, Y.-F. Pan, X.-M. Wu, Y. Yang, K. Bian, D.-D. Zhang, "Total Flavonoids from Radix Glycyrrhiza Exert Anti-Inflammatory and Antitumorigenic Effects by Inactivating iNOS Signaling Pathways," Evidence-Based Complementary and Alternative Medicine, vol. 2018,DOI: 10.1155/2018/6714282, 2018.
[11] Y. Xu, X.-X. Chen, Y.-X. Jiang, D.-D. Zhang, "Ethyl Acetate Fraction from Hedyotis diffusa plus Scutellaria barbata Exerts Anti-Inflammatory Effects by Regulating miR-155 Expression and JNK Signaling Pathway," Evidence-Based Complementary and Alternative Medicine, vol. 2018,DOI: 10.1155/2018/3593408, 2018.
[12] X. W. Chen, T. J. Yu, J. Zhang, Y. Li, H. L. Chen, G. F. Yang, W. Yu, Y. Z. Liu, X. X. Liu, C. F. Duan, H. L. Tang, M. Qiu, C. L. Wang, H. Zheng, J. Yue, A. M. Guo, J. Yang, "CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis," Oncogene, vol. 36 no. 35, pp. 5045-5057, DOI: 10.1038/onc.2017.118, 2017.
[13] D. R. Sharda, S. Yu, M. Ray, M. L. Squadrito, M. De Palma, T. A. Wynn, S. M. Morris, P. A. Hankey, "Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase," The Journal of Immunology, vol. 187 no. 5, pp. 2181-2192, DOI: 10.4049/jimmunol.1003460, 2011.
[14] Z. Czimmerer, B. Daniel, A. Horvath, D. Rückerl, G. Nagy, M. Kiss, M. Peloquin, M. M. Budai, I. Cuaranta-Monroy, Z. Simandi, L. Steiner, B. Nagy, S. Poliska, C. Banko, Z. Bacso, I. G. Schulman, S. Sauer, J.-F. Deleuze, J. E. Allen, S. Benko, L. Nagy, "The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages," Immunity, vol. 48 no. 1, pp. 75-90.e6, DOI: 10.1016/j.immuni.2017.12.010, 2018.
[15] T. S. Elton, H. Selemon, S. M. Elton, N. L. Parinandi, "Regulation of the MIR155 host gene in physiological and pathological processes," Gene, vol. 532 no. 1,DOI: 10.1016/j.gene.2012.12.009, 2013.
[16] D. F. Quail, J. A. Joyce, "Molecular pathways: Deciphering mechanisms of resistance to macrophage-targeted therapies," Clinical Cancer Research, vol. 23 no. 4, pp. 876-884, DOI: 10.1158/1078-0432.CCR-16-0133, 2017.
[17] B. Ruffell, N. I. Affara, L. M. Coussens, "Differential macrophage programming in the tumor microenvironment," Trends in Immunology, vol. 33 no. 3, pp. 119-126, DOI: 10.1016/j.it.2011.12.001, 2012.
[18] The Pharmacopoeia Commission of the Ministry of Health of the People’s Republic of China, Pharmacopoeia of the People’s Republic of China, 2015.
[19] O. R. Colegio, N.-Q. Chu, A. L. Szabo, T. Chu, A. M. Rhebergen, V. Jairam, N. Cyrus, C. E. Brokowski, S. C. Eisenbarth, G. M. Phillips, G. W. Cline, A. J. Phillips, R. Medzhitov, "Functional polarization of tumour-associated macrophages by tumour-derived lactic acid," Nature, vol. 513 no. 7519, pp. 559-563, DOI: 10.1038/nature13490, 2014.
[20] J. M. Brown, L. Recht, S. Strober, "The Promise of Targeting Macrophages in Cancer Therapy," Clinical Cancer Research, vol. 23 no. 13, pp. 3241-3250, DOI: 10.1158/1078-0432.CCR-16-3122, 2017.
[21] U. Schleicher, K. Paduch, A. Debus, S. Obermeyer, T. König, J. C. Kling, E. Ribechini, D. Dudziak, D. Mougiakakos, P. J. Murray, R. Ostuni, H. Körner, C. Bogdan, "TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection," Cell Reports, vol. 15 no. 5, pp. 1062-1075, DOI: 10.1016/j.celrep.2016.04.001, 2016.
[22] Z. Czimmerer, T. Varga, M. Kiss, C. O. Vázquez, Q. M. Doan-Xuan, D. Rückerl, S. G. Tattikota, X. Yan, Z. S. Nagy, B. Daniel, S. Poliska, A. Horvath, G. Nagy, E. Varallyay, M. N. Poy, J. E. Allen, Z. Bacso, C. Abreu-Goodger, L. Nagy, "The IL-4/STAT6 signaling axis establishes a conserved microRNA signature in human and mouse macrophages regulating cell survival via miR-342-3p," Genome Medicine, vol. 8 no. 1,DOI: 10.1186/s13073-016-0315-y, 2016.
[23] H. Li, T. Jiang, M.-Q. Li, X.-L. Zheng, G.-J. Zhao, "Transcriptional Regulation of Macrophages Polarization by MicroRNAs," Frontiers in Immunology, vol. 9,DOI: 10.3389/fimmu.2018.01175, 2018.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright © 2019 Yi-Xin Jiang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/
Abstract
Tumor-associated macrophages (TAMs) with M2 phenotype play an essential role in tumor microenvironment (TME) during the progression and development of numerous cancers and associated with poor prognosis. Thus, regulation of TAMs polarization emerged as a new strategy for tumor immune therapy. According to Traditional Chinese Medicine (TCM) theory, herbs with Qi-tonifying character are involved in improving the defense capacity of immune system. In this study, we screened extracts and ingredients from five Qi-tonifying herbs exhibiting an inhibitory effect on M2 polarization of murine macrophages RAW264.7 induced by IL-4 and IL-13. Among these candidates, total flavonoids from Glycyrrhiza Radix et Rhizoma (TFRG) and ethanol extract of Ginseng Radix et Rhizoma significantly inhibited the expression of Arginase-1 (Arg-1) (above 90% at 100μg/mL), one of the phenotype markers of M2 macrophages. The inhibition of total saponins of Ginseng Radix et Rhizoma, ethanol extract of Cordyceps, ethanol extract of Acanthopanacis senticosi Radix et Rhizoma Seu caulis, and ethanol extract of Astragali Radix reached above 50% at 100μg/mL. The inhibition of ingredients including glabridin, isoliquiritin apioside, lysionotin, cordycepin, astragaloside IV, and calycosin reached above 50% at 50μM. Then, we investigated the molecular mechanisms of TFRG. TFRG abolished the migration of murine breast cancer 4T1 stimulated by the conditioned medium from M2 macrophages (M2-CM). In addition to Arg-1, TFRG also antagonized the IL-4/13-mediated mRNA upregulation of the M2 markers including found in inflammatory zone 1 (FIZZ1), chitinase-3-like protein 3 (YM1), and mannose receptor (CD206) and upregulated the expression of inducible nitric oxide synthase (iNOS), one of the M1 markers. The further exploration showed that TFRG decreased the phosphorylation of STAT6 and increased the expression of miR-155. Our study provides a series of potential immune regulating natural products from five Qi-tonifying herbs on M2 phenotype. For instance, TFRG suppressed M2 polarization of macrophages partly by inactivating STAT6 pathway and enhanced the level of miR-155 to regulate the expressions of M1 and M2 markers.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Cailun Road 1200, Shanghai 201203, China
2 School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Cailun Road 1200, Shanghai 201203, China